| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.785 | 0.003 | 0.785 | Diuretic | 0.762 0.003 DBMET00995 | ||
| 0.766 | 0.004 | 0.808 | Vasodilator, peripheral | 0.808 0.004 DBMET00995 | DBMET00995 | |
| 0.649 | 0.009 | 0.649 | Spasmolytic | 0.496 0.024 DBMET00995 | ||
| 0.544 | 0.002 | 0.622 | Angiotensin-converting enzyme inhibitor | 0.622 0.002 DBMET00995 | DBMET00995 | |
| 0.539 | 0.011 | 0.539 | Vasodilator, coronary | 0.451 0.023 DBMET00995 | ||
| 0.521 | 0.01 | 0.521 | Vasodilator | 0.509 0.011 DBMET00995 | ||
| 0.507 | 0.028 | 0.507 | Immunostimulant | 0.492 0.03 DBMET00995 | ||
| 0.476 | 0.013 | 0.492 | Psychostimulant | 0.492 0.011 DBMET00995 | DBMET00995 | |
| 0.428 | 0.024 | 0.428 | Cardiotonic | 0.421 0.025 DBMET00995 | ||
| 0.441 | 0.07 | 0.476 | Cyclophilin D inhibitor | 0.476 0.058 DBMET00995 | DBMET00995 | |
| 0.39 | 0.052 | 0.39 | Antithrombotic | 0.363 0.06 DBMET00995 | ||
| 0.336 | 0.006 | 0.366 | Neurotrophic factor | 0.366 0.005 DBMET00995 | DBMET00995 | |
| 0.378 | 0.051 | 0.412 | Immunomodulator | 0.412 0.04 DBMET00995 | DBMET00995 | |
| 0.352 | 0.038 | 0.39 | Platelet antagonist | 0.39 0.029 DBMET00995 | DBMET00995 | |
| 0.385 | 0.083 | 0.385 | Histamine release inhibitor | 0.273 0.139 DBMET00995 | ||
| 0.342 | 0.049 | 0.406 | Interleukin 2 agonist | 0.406 0.026 DBMET00995 | DBMET00995 | |
| 0.324 | 0.038 | 0.358 | Interleukin agonist | 0.358 0.027 DBMET00995 | DBMET00995 | |
| 0.327 | 0.044 | 0.327 | Hypoglycemic | 0.296 0.054 DBMET00995 | ||
| 0.304 | 0.023 | 0.357 | Thrombolytic | 0.357 0.016 DBMET00995 | DBMET00995 | |
| 0.334 | 0.06 | 0.334 | 5 Hydroxytryptamine release stimulant | 0.226 0.102 DBMET00995 | ||
| 0.295 | 0.029 | 0.335 | Anticoagulant | 0.335 0.023 DBMET00995 | DBMET00995 | |
| 0.304 | 0.048 | 0.326 | Angiogenesis stimulant | 0.326 0.04 DBMET00995 | DBMET00995 | |
| 0.353 | 0.113 | 0.353 | 5 Hydroxytryptamine release inhibitor | |||
| 0.241 | 0.004 | 0.241 | Acetylcholine release stimulant | 0.159 0.012 DBMET00995 | ||
| 0.315 | 0.082 | 0.315 | Cholesterol antagonist | 0.236 0.136 DBMET00995 | ||
| 0.233 | 0.004 | 0.233 | Leukocyte elastase inhibitor | 0.155 0.005 DBMET00995 | ||
| 0.227 | 0.002 | 0.246 | Prolyl endopeptidase inhibitor | 0.246 0.002 DBMET00995 | DBMET00995 | |
| 0.274 | 0.054 | 0.321 | Gastrin inhibitor | 0.321 0.021 DBMET00995 | DBMET00995 | |
| 0.339 | 0.126 | 0.339 | Calcium channel L-type activator | 0.262 0.193 DBMET00995 | ||
| 0.239 | 0.029 | 0.239 | Thiol protease inhibitor | 0.214 0.035 DBMET00995 | ||
| 0.224 | 0.016 | 0.268 | Aminopeptidase B inhibitor | 0.268 0.011 DBMET00995 | DBMET00995 | |
| 0.299 | 0.095 | 0.299 | Transcription factor NF kappa B inhibitor | 0.268 0.115 DBMET00995 | ||
| 0.307 | 0.111 | 0.307 | Immunosuppressant | 0.306 0.111 DBMET00995 | ||
| 0.263 | 0.085 | 0.268 | Insulysin inhibitor | 0.268 0.081 DBMET00995 | DBMET00995 | |
| 0.307 | 0.137 | 0.346 | Analgesic | 0.346 0.11 DBMET00995 | DBMET00995 | |
| 0.185 | 0.029 | 0.228 | Cell adhesion inhibitor | 0.228 0.018 DBMET00995 | DBMET00995 | |
| 0.19 | 0.041 | 0.223 | Neurotensin receptor agonist | 0.223 0.026 DBMET00995 | DBMET00995 | |
| 0.173 | 0.035 | 0.173 | Proteasome inhibitor | 0.154 0.044 DBMET00995 | ||
| 0.2 | 0.064 | 0.2 | P-glycoprotein inhibitor | 0.177 0.082 DBMET00995 | ||
| 0.174 | 0.04 | 0.174 | Anesthetic local | |||
| 0.123 | 0.006 | 0.189 | Dipeptidyl peptidase inhibitor | 0.189 0.004 DBMET00995 | DBMET00995 | |
| 0.178 | 0.068 | 0.257 | Growth hormone agonist | 0.257 0.042 DBMET00995 | DBMET00995 | |
| 0.216 | 0.11 | 0.235 | Tyrosine 3 hydroxylase inhibitor | 0.235 0.084 DBMET00995 | DBMET00995 | |
| 0.127 | 0.021 | 0.161 | Cell adhesion molecule inhibitor | 0.161 0.013 DBMET00995 | DBMET00995 | |
| 0.118 | 0.013 | 0.118 | Elastase 1 inhibitor | 0.103 0.019 DBMET00995 | ||
| 0.238 | 0.141 | 0.295 | Sodium/bile acid cotransporter inhibitor | 0.295 0.084 DBMET00995 | DBMET00995 | |
| 0.098 | 0.005 | 0.109 | Prolactin release inhibitor | 0.109 0.004 DBMET00995 | DBMET00995 | |
| 0.142 | 0.053 | 0.203 | Cathepsin H inhibitor | 0.203 0.022 DBMET00995 | DBMET00995 | |
| 0.124 | 0.036 | 0.167 | Folate antagonist | 0.167 0.017 DBMET00995 | DBMET00995 | |
| 0.129 | 0.041 | 0.129 | Protease inhibitor | 0.127 0.042 DBMET00995 | ||
| 0.091 | 0.003 | 0.165 | Angiotensin-converting enzyme 2 inhibitor | 0.165 0.003 DBMET00995 | DBMET00995 | |
| 0.113 | 0.025 | 0.131 | Analgesic, opioid | 0.131 0.019 DBMET00995 | DBMET00995 | |
| 0.213 | 0.128 | 0.32 | 5 Hydroxytryptamine uptake stimulant | 0.32 0.036 DBMET00995 | DBMET00995 | |
| 0.098 | 0.014 | 0.205 | NMDA 2A receptor antagonist | 0.205 0.005 DBMET00995 | DBMET00995 | |
| 0.119 | 0.037 | 0.155 | Opioid antagonist | 0.155 0.024 DBMET00995 | DBMET00995 | |
| 0.104 | 0.023 | 0.104 | Calcium channel L-type blocker | |||
| 0.118 | 0.037 | 0.127 | Interleukin 1 beta converting enzyme inhibitor | 0.127 0.03 DBMET00995 | DBMET00995 | |
| 0.083 | 0.005 | 0.127 | Neutral endopeptidase inhibitor | 0.127 0.004 DBMET00995 | DBMET00995 | |
| 0.085 | 0.009 | 0.103 | HCV NS3/NS4A protease inhibitor | 0.103 0.004 DBMET00995 | DBMET00995 | |
| 0.087 | 0.014 | 0.087 | Elastase inhibitor | 0.084 0.014 DBMET00995 | ||
| 0.109 | 0.042 | 0.181 | NMDA receptor antagonist | 0.181 0.017 DBMET00995 | DBMET00995 | |
| 0.095 | 0.029 | 0.101 | Thrombin inhibitor | 0.101 0.025 DBMET00995 | DBMET00995 | |
| 0.101 | 0.035 | 0.116 | Hematopoietic | 0.116 0.024 DBMET00995 | DBMET00995 | |
| 0.074 | 0.009 | 0.126 | Dipeptidyl peptidase IV inhibitor | 0.126 0.004 DBMET00995 | DBMET00995 | |
| 0.135 | 0.072 | 0.144 | Bone formation stimulant | 0.144 0.064 DBMET00995 | DBMET00995 | |
| 0.095 | 0.033 | 0.128 | Opioid mu receptor antagonist | 0.128 0.023 DBMET00995 | DBMET00995 | |
| 0.169 | 0.108 | 0.174 | Insulin sensitizer | 0.174 0.103 DBMET00995 | DBMET00995 | |
| 0.105 | 0.052 | 0.115 | Falcipain inhibitor | 0.115 0.046 DBMET00995 | DBMET00995 | |
| 0.093 | 0.043 | 0.109 | Opioid kappa receptor antagonist | 0.109 0.028 DBMET00995 | DBMET00995 | |
| 0.101 | 0.051 | 0.111 | Falcipain 2 inhibitor | 0.111 0.046 DBMET00995 | DBMET00995 | |
| 0.083 | 0.035 | 0.125 | Opioid delta receptor antagonist | 0.125 0.025 DBMET00995 | DBMET00995 | |
| 0.136 | 0.089 | 0.153 | Insulin secretagoues | 0.153 0.072 DBMET00995 | DBMET00995 | |
| 0.09 | 0.043 | 0.09 | Chymotrypsin inhibitor | 0.086 0.048 DBMET00995 | ||
| 0.053 | 0.007 | 0.069 | Glutamate (mGluR8) antagonist | 0.069 0.004 DBMET00995 | DBMET00995 | |
| 0.139 | 0.094 | 0.171 | Interferon gamma antagonist | 0.171 0.056 DBMET00995 | DBMET00995 | |
| 0.074 | 0.03 | 0.082 | Trypsin inhibitor | 0.082 0.026 DBMET00995 | DBMET00995 | |
| 0.151 | 0.108 | 0.151 | Hepatoprotectant | 0.138 0.124 DBMET00995 | ||
| 0.054 | 0.012 | 0.058 | Baculoviral IAP repeat-containing protein inhibitor | 0.058 0.007 DBMET00995 | DBMET00995 | |
| 0.068 | 0.031 | 0.073 | Cathepsin E inhibitor | 0.073 0.027 DBMET00995 | DBMET00995 | |
| 0.046 | 0.01 | 0.053 | Bradykinin B2 receptor antagonist | 0.053 0.005 DBMET00995 | DBMET00995 | |
| 0.041 | 0.005 | 0.045 | HCV NS5A inhibitor | 0.045 0.004 DBMET00995 | DBMET00995 | |
| 0.088 | 0.052 | 0.103 | Factor XII inhibitor | 0.103 0.035 DBMET00995 | DBMET00995 | |
| 0.069 | 0.034 | 0.069 | Nitric oxide donor | |||
| 0.065 | 0.031 | 0.065 | Human rhinovirus A protease inhibitor | 0.06 0.034 DBMET00995 | ||
| 0.051 | 0.02 | 0.065 | Glutamate (mGluR4) antagonist | 0.065 0.012 DBMET00995 | DBMET00995 | |
| 0.076 | 0.046 | 0.138 | Aminopeptidase I inhibitor | 0.138 0.015 DBMET00995 | DBMET00995 | |
| 0.049 | 0.02 | 0.054 | Leukotriene A4 hydrolase inhibitor | 0.054 0.018 DBMET00995 | DBMET00995 | |
| 0.068 | 0.039 | 0.068 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.079 | 0.052 | 0.091 | Somatostatin 1 agonist | 0.091 0.04 DBMET00995 | DBMET00995 | |
| 0.044 | 0.018 | 0.08 | Bradykinin antagonist | 0.08 0.008 DBMET00995 | DBMET00995 | |
| 0.074 | 0.049 | 0.084 | Cathepsin G inhibitor | 0.084 0.041 DBMET00995 | DBMET00995 | |
| 0.082 | 0.058 | 0.082 | Acetylcholine M3 receptor agonist | |||
| 0.036 | 0.013 | 0.044 | Bradykinin B2 receptor agonist | 0.044 0.01 DBMET00995 | DBMET00995 | |
| 0.032 | 0.009 | 0.032 | Elastase 2A inhibitor | 0.028 0.01 DBMET00995 | ||
| 0.032 | 0.009 | 0.032 | Elastase 2 inhibitor | 0.028 0.01 DBMET00995 | ||
| 0.047 | 0.025 | 0.059 | Glutamate (mGluR group III) antagonist | 0.059 0.014 DBMET00995 | DBMET00995 | |
| 0.046 | 0.027 | 0.057 | Opioid kappa receptor agonist | 0.057 0.02 DBMET00995 | DBMET00995 | |
| 0.032 | 0.012 | 0.046 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.046 0.005 DBMET00995 | DBMET00995 | |
| 0.044 | 0.028 | 0.064 | Cholecystokinin antagonist | 0.064 0.017 DBMET00995 | DBMET00995 | |
| 0.097 | 0.081 | 0.097 | Mucolytic | |||
| 0.044 | 0.032 | 0.071 | Neurotensin receptor antagonist | 0.071 0.02 DBMET00995 | DBMET00995 | |
| 0.05 | 0.04 | 0.061 | Opioid agonist | 0.061 0.029 DBMET00995 | DBMET00995 | |
| 0.044 | 0.035 | 0.065 | Endothelin-converting enzyme inhibitor | 0.065 0.022 DBMET00995 | DBMET00995 | |
| 0.033 | 0.024 | 0.043 | Calcitonin receptor agonist | 0.043 0.019 DBMET00995 | DBMET00995 | |
| 0.034 | 0.027 | 0.059 | Arginase inhibitor | 0.059 0.011 DBMET00995 | DBMET00995 | |
| 0.029 | 0.023 | 0.04 | Cholecystokinin B antagonist | 0.04 0.014 DBMET00995 | DBMET00995 | |
| 0.02 | 0.015 | 0.021 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.021 0.012 DBMET00995 | DBMET00995 | |
| 0.042 | 0.038 | 0.049 | Opioid mu receptor agonist | 0.049 0.03 DBMET00995 | DBMET00995 | |
| 0.057 | 0.054 | 0.06 | Caspase 9 inhibitor | 0.06 0.047 DBMET00995 | DBMET00995 | |
| 0.02 | 0.017 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 DBMET00995 | DBMET00995 | |
| 0.015 | 0.012 | 0.016 | CC chemokine 10 receptor antagonist | 0.016 0.008 DBMET00995 | DBMET00995 | |
| 0.054 | 0.052 | 0.054 | Neuraminidase inhibitor | |||
| 0.04 | 0.039 | 0.045 | Plasmin inhibitor | 0.045 0.035 DBMET00995 | DBMET00995 | |
| 0.027 | 0.026 | 0.032 | Dipeptidyl peptidase I inhibitor | 0.032 0.019 DBMET00995 | DBMET00995 | |
| 0.069 | 0.069 | 0.074 | Acetylcholine nicotinic antagonist | 0.074 0.063 DBMET00995 | DBMET00995 | |
| 0.014 | 0.014 | 0.017 | Dipeptidyl peptidase IX inhibitor | 0.017 0.01 DBMET00995 | DBMET00995 | |
| 0.012 | 0.014 | 0.028 | Integrin alpha4beta1 antagonist | 0.028 0.007 DBMET00995 | DBMET00995 | |
| 0.053 | 0.054 | 0.086 | Glucagon-like peptide 1 agonist | 0.086 0.031 DBMET00995 | DBMET00995 | |
| 0.013 | 0.015 | 0.015 | Dipeptidyl peptidase VIII inhibitor | 0.015 0.011 DBMET00995 | DBMET00995 | |
| 0.191 | 0.193 | 0.196 | Apoptosis antagonist | 0.196 0.184 DBMET00995 | DBMET00995 | |
| 0.061 | 0.063 | 0.07 | Glutamate (mGluR6) antagonist | 0.07 0.041 DBMET00995 | DBMET00995 | |
| 0.053 | 0.056 | 0.084 | NMDA 2C receptor antagonist | 0.084 0.023 DBMET00995 | DBMET00995 | |
| 0.031 | 0.034 | 0.084 | NMDA receptor subunit 3A antagonist | 0.084 0.011 DBMET00995 | DBMET00995 | |
| 0.031 | 0.035 | 0.039 | Nicotinic receptor beta4 subunit antagonist | 0.039 0.024 DBMET00995 | DBMET00995 | |
| 0.039 | 0.043 | 0.054 | GP IIb/IIIa receptor antagonist | 0.054 0.03 DBMET00995 | DBMET00995 | |
| 0.032 | 0.037 | 0.037 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.02 DBMET00995 | DBMET00995 | |
| 0.035 | 0.04 | 0.042 | Integrin alpha1beta1 antagonist | 0.042 0.017 DBMET00995 | DBMET00995 | |
| 0.015 | 0.021 | 0.018 | Tryptophan hydroxylase 1 inhibitor | 0.018 0.009 DBMET00995 | DBMET00995 | |
| 0.031 | 0.037 | 0.036 | HCV polyprotein inhibitor | 0.036 0.018 DBMET00995 | DBMET00995 | |
| 0.024 | 0.031 | 0.033 | Caspase 2 inhibitor | 0.033 0.021 DBMET00995 | DBMET00995 | |
| 0.029 | 0.037 | 0.035 | Somatostatin 1 antagonist | 0.035 0.03 DBMET00995 | DBMET00995 | |
| 0.014 | 0.022 | 0.026 | Angiotensin AT2 receptor antagonist | 0.026 0.014 DBMET00995 | DBMET00995 | |
| 0.2 | 0.208 | 0.247 | Antiobesity | 0.247 0.159 DBMET00995 | DBMET00995 | |
| 0.039 | 0.048 | 0.051 | Metalloproteinase-3 inhibitor | 0.051 0.032 DBMET00995 | DBMET00995 | |
| 0.028 | 0.037 | 0.039 | Carboxypeptidase B inhibitor | 0.039 0.014 DBMET00995 | DBMET00995 | |
| 0.02 | 0.03 | 0.047 | Lysine carboxypeptidase inhibitor | 0.047 0.008 DBMET00995 | DBMET00995 | |
| 0.052 | 0.065 | 0.076 | Matrix metalloproteinase inhibitor | 0.076 0.039 DBMET00995 | DBMET00995 | |
| 0.042 | 0.057 | 0.054 | Aminopeptidase microsomal inhibitor | 0.054 0.044 DBMET00995 | DBMET00995 | |
| 0.112 | 0.127 | 0.133 | Sigma receptor agonist | 0.133 0.099 DBMET00995 | DBMET00995 | |
| 0.041 | 0.057 | 0.055 | Plasminogen activator inhibitor | 0.055 0.043 DBMET00995 | DBMET00995 | |
| 0.019 | 0.035 | 0.045 | AMPA 2 receptor antagonist | 0.045 0.012 DBMET00995 | DBMET00995 | |
| 0.014 | 0.031 | 0.049 | Integrin alpha4 antagonist | 0.049 0.011 DBMET00995 | DBMET00995 | |
| 0.033 | 0.051 | 0.059 | Nicotinic receptor alpha3 subunit antagonist | 0.059 0.02 DBMET00995 | DBMET00995 | |
| 0.02 | 0.037 | 0.025 | NMDA 2D receptor antagonist | 0.025 0.023 DBMET00995 | DBMET00995 | |
| 0.04 | 0.057 | 0.049 | Collagenase inhibitor | 0.049 0.034 DBMET00995 | DBMET00995 | |
| 0.01 | 0.028 | 0.023 | Aminopeptidase A inhibitor | 0.023 0.009 DBMET00995 | DBMET00995 | |
| 0.042 | 0.065 | 0.054 | Matrix metalloproteinase (membrane-type) inhibitor | 0.054 0.039 DBMET00995 | DBMET00995 | |
| 0.021 | 0.051 | 0.075 | Integrin antagonist | 0.075 0.021 DBMET00995 | DBMET00995 | |
| 0.009 | 0.039 | 0.019 | Integrin alpha4beta7 antagonist | 0.019 0.017 DBMET00995 | DBMET00995 | |
| 0.059 | 0.089 | 0.09 | Metalloproteinase-2 inhibitor | 0.09 0.044 DBMET00995 | DBMET00995 | |
| 0.018 | 0.049 | 0.032 | LFA antagonist | 0.032 0.013 DBMET00995 | DBMET00995 | |
| 0.071 | 0.102 | 0.169 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.169 0.022 DBMET00995 | DBMET00995 | |
| 0.047 | 0.08 | 0.132 | NMDA 2 receptor antagonist | 0.132 0.02 DBMET00995 | DBMET00995 | |
| 0.071 | 0.109 | 0.114 | Falcipain 3 inhibitor | 0.114 0.058 DBMET00995 | DBMET00995 | |
| 0.122 | 0.16 | 0.138 | Lipocortins synthesis antagonist | 0.138 0.125 DBMET00995 | DBMET00995 | |
| 0.019 | 0.06 | 0.046 | Complement C3a chemotactic receptor antagonist | 0.046 0.029 DBMET00995 | DBMET00995 | |
| 0.022 | 0.062 | 0.034 | Dipeptidyl peptidase II inhibitor | 0.034 0.02 DBMET00995 | DBMET00995 | |
| 0.02 | 0.063 | 0.061 | Kainate receptor antagonist | 0.061 0.015 DBMET00995 | DBMET00995 | |
| 0.027 | 0.071 | 0.05 | Ribonucleoside-diphosphate reductase inhibitor | 0.05 0.041 DBMET00995 | DBMET00995 | |
| 0.025 | 0.069 | 0.038 | Integrin alpha5beta1 antagonist | 0.038 0.033 DBMET00995 | DBMET00995 | |
| 0.026 | 0.074 | 0.049 | Ribonucleotide reductase inhibitor | 0.049 0.043 DBMET00995 | DBMET00995 | |
| 0.005 | 0.056 | 0.037 | Kainate receptor 1 antagonist | 0.037 0.008 DBMET00995 | DBMET00995 | |
| 0.025 | 0.079 | 0.095 | NMDA receptor subunit 3B antagonist | 0.095 0.011 DBMET00995 | DBMET00995 | |
| 0.022 | 0.084 | 0.033 | Glutamate (mGluR3) agonist | 0.033 0.02 DBMET00995 | DBMET00995 | |
| 0.079 | 0.142 | 0.125 | Alpha-N-acetylglucosaminidase inhibitor | 0.125 0.073 DBMET00995 | DBMET00995 | |
| 0.005 | 0.074 | 0.024 | VLA-4 antagonist | 0.024 0.02 DBMET00995 | DBMET00995 | |
| 0.082 | 0.161 | 0.108 | Histone deacetylase SIRT1 inhibitor | 0.108 0.107 DBMET00995 | DBMET00995 | |
| 0.069 | 0.149 | 0.117 | Glutamate receptor antagonist | 0.117 0.077 DBMET00995 | DBMET00995 | |
| 0.114 | 0.204 | 0.14 | Phospholipase C inhibitor | 0.14 0.127 DBMET00995 | DBMET00995 | |
| 0.117 | 0.211 | 0.13 | Heat shock protein 70 antagonist | 0.13 0.122 DBMET00995 | DBMET00995 | |
| 0.053 | 0.151 | 0.118 | Prolactin inhibitor | 0.118 0.039 DBMET00995 | DBMET00995 | |
| 0.035 | 0.139 | 0.063 | NMDA receptor agonist | 0.063 0.043 DBMET00995 | DBMET00995 | |
| 0.017 | 0.123 | 0.042 | Glutamate (mGluR3) antagonist | 0.042 0.019 DBMET00995 | DBMET00995 | |
| 0.01 | 0.116 | 0.036 | Kainate receptor 2 antagonist | 0.036 0.024 DBMET00995 | DBMET00995 | |
| 0.023 | 0.167 | 0.042 | Kainate receptor agonist | 0.042 0.026 DBMET00995 | DBMET00995 | |
| 0.104 | 0.286 | 0.173 | Superoxide dismutase inhibitor | 0.173 0.151 DBMET00995 | DBMET00995 | |
| 0.018 | 0.235 | 0.084 | Glutamate receptor agonist | 0.084 0.049 DBMET00995 | DBMET00995 | |
| 0.014 | 0.241 | 0.037 | AMPA 4 receptor antagonist | 0.037 0.032 DBMET00995 | DBMET00995 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |